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Objective. To describe the prevalence and correlates of dual-contraceptive methods use (condoms and an eﬀective pregnancy
prevention method) and barriers to their use among married persons living with HIV (PLHIV) in India. Methods.W ec o n d u c t e d
a quantitative survey (93 men, 97 women), 25 in-depth interviews, seven focus groups, and ﬁve key informant interviews. Results.
Prevalence of dual- contraceptive method use increased from 5% before HIV diagnosis to 23% after diagnosis (P<0.001).
Condoms were the most common contraceptive method, with prevalence increasing from 13% before diagnosis to 92% after
diagnosis (P<0.001). Barriers to using noncondom contraceptives were lack of discussion about noncondom contraceptives by
health care providers, lack of acceptability of noncondom contraceptives among PLHIV, and lack of involvement of husbands in
family planning counseling. Conclusion. There is a need for interventions, including training of health care providers, to increase
dual-contraceptive methods use among married PLHIV.
1.Introduction
The sexual and reproductive health of persons living with
HIV (PLHIV) is fundamental to their well-being and that of
their partners and children. In 2008, there were an estimated
2.27 million PLHIV in India [1], most of whom were adults
in the sexually active and reproductive age range and about
two-ﬁfths of whom were women [1].
The major risk for HIV transmission in India is sexual
intercourse [1], with most married women living with HIV
having acquired it from their husband [2, 3]. Because in-
creased availability of antiretroviral treatment and manage-
ment of opportunistic infections have greatly improved the
prognosis for PLHIV in India, married PLHIV in the repro-
ductive age range face important reproductive health and
family planning decisions. Couples who desire to initiate a
pregnancy require careful counselling regarding conception,
antenatal care, and childbirth to minimize the risks of trans-
mitting HIV to children and uninfected partners; couples
who do not intend to initiate a pregnancy require eﬀective
contraception along with protection against both sexually
transmitted infections (STIs) and infection or reinfection
with HIV [4].
Simultaneous protection against both unwanted preg-
nancy and STIs/HIV is referred to as dual protection
[5]. Theoretically, dual protection can be accomplished by
consistent male condom use alone; however, typical use
of male condoms (hereafter referred to as condoms) as
a contraceptive method results in a one-year cumulative
incidence of unintended pregnancy of about 15% [6].2 Infectious Diseases in Obstetrics and Gynecology
Other contraceptive methods, including male and female
sterilization, intrauterine devices (IUDs), and oral hormonal
contraceptives, are much more eﬀective than condoms in
preventing pregnancy, but do not protect against STIs/HIV
[6, 7]. Thus, the most prudent approach to dual protection
is the use of dual-contraceptive methods: condom use
in combination with a highly eﬀective pregnancy preven-
tion method. Although promotion and adoption of dual-
contraceptive methods pose more challenges than promo-
tion of a single method (e.g., condoms), in a setting where
both unintended pregnancy and STI/HIV transmission are
of great concern, adoption of dual-contraceptive methods
is necessary for optimal sexual and reproductive health
[7].
In 2006, we conducted a mixed-methods study of sexual
and reproductive health of PLHIV in India [8]. Here we
describe results from this study about prevalence of use of
contraceptive methods by married men and women living
with HIV, prior to and after their HIV diagnosis, assess
factors related to their dual-contraceptive methods use after
their HIV diagnosis, and assess barriers to the use of dual-
contraceptive methods.
2.MaterialsandMethods
We used a concurrent triangulation mixed-methods design
[9], in which we conducted a quantitative survey, qualita-
tive in-depth interviews, focus group discussions (FGDs),
and key informant interviews from August to November
2006. The goal of using mixed methods was to provide a
comprehensive understanding of the phenomenon of dual-
contraceptive methods use. The quantitative component
primarily explored the prevalence and correlates of dual-
contraceptive methods use, and the qualitative component
focused on the experiences of using one or more contracep-
tive methods and explored barriers to use of a noncondom
contraceptive method.
Werecruitedheterosexualmenandwomenfromdistrict-
level PLHIV networks of the Indian Network for People Liv-
ing with HIV (INP+) in ﬁve Indian states (Tamil Nadu, And-
hra Pradesh, Maharashtra, West Bengal, and Uttar Pradesh).
Eligible participants were known to be HIV positive for at
least one year, 18 years of age or older, sexually active in the
past 3 months, and able to understand and give consent to
the study. The study protocol was reviewed and approved by
the Institutional Review Board at the University of Toronto,
Canada, and by a community advisory board constituted by
INP+. All participants except key informants were paid 250
Indian rupees.
2.1. Quantitative Component. We used systematic sampling
to recruit every kth eligible heterosexual man or woman
living with HIV, respectively, who attended INP+ support
group meetings and drop-in centres of the participating
district-level PLHIV networks. This was a simple approach
to essentially obtain a random sample. The value of “k”w a s
site speciﬁc. Overall, we recruited 100 men and 100 women.
In the present study, we restricted the quantitative analyses
to those who reported being currently married (93 men, 97
women).
Using a structured questionnaire, trained interviewers
asked participants about their current contraceptive use
and their contraceptive use prior to their HIV diagnosis.
Participants were asked, “Before you tested positive for HIV,
did you or your partner ever used any contraceptive/fam-
ily planning method?” Participants who answered “yes” were
then asked, “Which contraceptive/family planning method
did you or your partner use?” and were read the following
options: the pill, IUD, condom, spermicide, calendar
method, injectables, tubal ligation, and vasectomy. Partici-
pants were also asked, “Are you or your partner currently
using any contraceptive/family planning method?” Partici-
pants who answered “yes” were then asked, “Which contra-
ceptive/family planning methods are you currently using?”
and were read the options listed above.
Participants who reported using the pill (oral hormonal
contraception), an IUD, injectables, tubal ligation, or vasect-
omy were scored as using an eﬀective contraceptive (preg-
nancy prevention) method (known to have greater than
90% eﬀectiveness against pregnancy) [6]. Participants who
reportedusinganeﬀectivepregnancypreventionmethodand
condoms were scored as using a dual-contraceptive method.
The survey also assessed demographic, medical, and be-
havioural covariates, including age, gender, alcohol consum-
ption in the past 3 months, age at ﬁrst sexual intercourse,
whether the participant had a casual sex partner (“your sex-
ualpartnerwhomyouhavenotmetbeforehavingsexorwith
whom you have had only casual acquaintance”) in the past 3
months, principal reasons for using contraceptives (to pre-
vent unwanted pregnancy, to prevent the risk of transmis-
sion of HIV to their partner, to prevent getting STIs, to
prevent having an HIV-infected baby, and/or partner’s pre-
ference for contraceptives), HIV status of spouse, years since
HIV diagnosis, whether the participant received post-test
HIV counselling, whether the participant was currently on
antiretroviral drugs, and last CD4 cell count.
2.2. Qualitative Component. We recruited heterosexual
PLHIV to participate in in-depth interviews and FGDs us-
ing snowball sampling, with PLHIV associated with the
participating district-level networks serving as seeds, and
purposive sampling, to ensure inclusion of persons with
seroconcordant and serodiscordant spouses. In-depth inter-
views were conducted with 25 PLHIV (14 men, 11 women)
who reported currently being married and living with their
spouse. The interview included open-ended questions to ex-
plore the contexts of unprotected and safer sex, current and
pastuseofcondomsandothercontraceptives,reasonsforuse
ornonuseofvariouscontraceptivemethods,andexperiences
in using those methods. A total of 7 FGDs were conducted
withmarriedPLHIV.EachFGDwassinglegender:threewith
men (n = 15) and four with women (n = 28). Discussions
focused on sexual and reproductive health needs, use of con-
traceptives, and prevention challenges.
Key informant interviews were conducted with three
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and one PLHIV community leader. A community debrieﬁng
meeting was conducted with peer research staﬀ and key
PLHIV community leaders where the ﬁndings were shared
and feedback was obtained as a form of “member checking”
to enhance the validity of the ﬁndings [10].
2.3. Data Analyses. We conducted parallel mixed data anal-
ysis [11] in which the quantitative and qualitative data were
ﬁrst analysed separately and then compared and contrasted.
We described results using frequencies and proportions
and used McNemar tests to compare contraception method
use prior to and after HIV diagnosis. We used a multivariate
logistic regression model with forward selection (using P<
0.05astheentrycriterion)tocalculateoddsratios(ORs)and
corresponding 95% conﬁdence intervals (CIs) for potential
demographic, medical, and behavioural correlates of dual-
contraceptive methods. The variables considered were age,
gender, alcohol consumption in the past 3 months, age at
ﬁrst sexual intercourse, whether the participant had a casual
sex partner in the past 3 months, principal reasons for using
contraceptives (to prevent unwanted pregnancy, to prevent
the risk of transmission of HIV to their partner, to pre-
vent getting STIs, to prevent having an HIV-infected baby,
and/or partner’s preference for contraceptives), HIV status
of spouse, years since HIV diagnosis, whether the participant
received posttest HIV counselling, whether the participant
was currently on antiretroviral drugs, and last CD4 cell
count. To aid in the interpretation of the odds ratio for the
CD4 count, the count was divided by 50 so that the odds
ratio represented the change in odds for every increase in
50cells/mL of the CD4 count. Statistical analyses were per-
formed with SPSS 17.
In-depth interviews and FGDs were audiotaped, tran-
scribed verbatim in native languages, and translated into
English.Datawereexploredusingnarrativethematicanalysis
and a constant comparative method from grounded theory
[12, 13].
3. Results
3.1. Sample Characteristics. Sociodemographic characteris-
tics of study participants are presented in Table 1.T h em e a n
age of the survey sample (93 men, 97 women) was 34.1 ±5.2
years for men and 28.3±4.3 years for women. Sixty-two per-
cent of the men and 71% of the women did not complete
high school. Seventy percent of the men and 92% of the
women reported being in HIV-seroconcordant relationships.
Most PLHIV reported having disclosed their HIV status to
their spouse (90% of men, 94% of women). Three men, but
no women, reported having a regular sexual partner other
than their spouse in the past 3 months. Thirteen men and
two women reported having one or more casual partners in
the past 3 months.
Twenty-ﬁve married PLHIV (14 men, 11 women) partic-
ipated in in-depth interviews (Table 1). Their mean age was
31.3 ± 4.6 years. Half (52%) did not complete high school.
Half (52%) were volunteer peer educators or part-time peer
outreach workers for district-level PLHIV networks.
A total of 43 married PLHIV (15 men, 28 women) par-
ticipated in 7 FGDs (Table 1). The mean age of the FGD
participants was 30.3 ± 5.1 years. More than half (58%) did
notcompletehighschool. Aboutone-third(37%)werevolu-
nteer peer educators or part-time peer outreach workers for
district-level PLHIV networks.
3.2. Use of Contraceptives among Married PLHIV: Quanti-
tative Findings. Table 2 describes contraceptive use before
and after HIV diagnosis among married PLHIV. Condoms
were the most commonly reported contraceptive method
used by married PLHIV prior to and after their HIV diag-
nosis, followed by tubal ligation. Whereas only 28% of
PLHIV (30% of men, 27% of women) reported using any
contraceptive prior to their HIV diagnosis, 95% of PLHIV
reported currently using a contraceptive (96% of men, 95%
of women). This increase, which was highly signiﬁcant (P<
0.001), was mainly due to condom use increasing from 13%
ofmarriedPLHIV(15%ofmen;11%ofwomen)beforeHIV
diagnosis to 92% (92% of men, 92% of women) after diag-
nosis (P<0.001).
Use of any eﬀective pregnancy prevention method (the
pill, an IUD, injectables, or sterilization) increased from 19%
of married PLHIV (18% of men, 21% of women) prior to
HIV diagnosis to 25% (18% of men, 31% of women) after
HIV diagnosis. However, this increase was not statistically
signiﬁcant (P = 0.20). The increase in tubal ligation use was
statisticallysigniﬁcant(P<0.01),whereastheincreaseinuse
of the pill was not statistically signiﬁcant (P = 0.33). The
other eﬀective pregnancy prevention methods (injectables,
IUDs, and vasectomy) were used too infrequently to assess
change.
3.3. Use of Dual-Contraceptive Methods among Married
PLHIV: Quantitative Findings. Five percent of married
PLHIV reported use of dual-contraceptive methods prior to
their HIV diagnosis (4% of men, 5% of women), which sig-
niﬁcantly increased to 23% of married PLHIV after their
diagnosis (15% of men, 30% of women) (P<0.001). Thus,
over three-fourths of the participants did not use dual-con-
traceptive methods following their HIV diagnosis; instead,
70% only used condoms (77% of men, 63% of women), 3%
only used an eﬀective pregnancy prevention method (3% of
men, 2% of women), and 5% used neither (4% of men, 6%
of women).
When we explored demographic, medical, and behav-
ioral factors associated with dual-contraceptive methods use
after HIV diagnosis, the ﬁnal model after forward selection
included ﬁve variables (Table 3). Married PLHIV were sig-
niﬁcantly more likely to report using dual-contraceptive
methods if they were female (OR = 2.93, 95% CI = 1.29–
6.67), had received posttest HIV counseling (OR = 2.96, 95%
CI = 1.22–7.19), used contraception to prevent the risk of
transmission of HIV to their partner (OR = 2.30, 95% CI =
1.01–5.20),orusedcontraceptionduetopartner’spreference
(OR = 2.76, 95% CI = 1.08–7.06). Furthermore, married
PLHIV were signiﬁcantly less likely to report using dual-
contraceptive methods if they had a higher CD4 cell count4 Infectious Diseases in Obstetrics and Gynecology
Table 1: Sociodemographic characteristics of study participants.
Quantitative survey Qualitative component
Characteristic Men
(N = 93)
Women
(N = 97)
In-depth Interviews
(N = 25)
Focus group
discussions (N = 43)
Sex
Male 93 (100%) — 14 (56%) 15 (35%)
Female — 97 (100%) 11 (44%) 28 (65%)
Age (years)
18–29 21 (23%) 58 (60%) 7 (28%) 16 (37%)
30–39 57 (61%) 38 (39%) 17 (68%) 23 (53%)
40–49 15 (16%) 1 (1%) 1 (4%) 4 (9%)
Education
<primary 17 (18%) 31 (32%) 1 (4%) 4 (9%)
Primary (5th STD) 19 (20%) 19 (20%) 6 (24%) 9 (21%)
Elementary (8th STD) 22 (24%) 19 (20%) 6 (24%) 12 (28%)
High school (10th STD) 21 (23%) 20 (21%) 7 (28%) 11 (26%)
Higher secondary (12th STD) 9 (10%) 6 (6%) 0 (0%) 5 (12%)
College or higher 5 (5%) 2 (2%) 5 (20%) 2 (5%)
Occupation
Daily wage laborer 40 (43%) 25 (26%) 2 (8%) 2 (5%)
Private company staﬀ 10 (11%) 7 (7%) 1 (4%) 3 (7%)
Peer educator/outreach worker for
PLHIV network 12 (13%) 10 (10%) 13 (52%) 16 (37%)
Self-employed 18 (19%) 3 (3%) 2 (8%) 3 (7%)
Homemaker 0 (0%) 34 (35%) 3 (12%) 12 (28%)
Unemployed 10 (11%) 15 (15%) 2 (8%) 2 (5%)
Other 3 (3%) 3 (3%) 2 (8%) 5 (12%)
Table 2: Use of contraceptives before and after HIV diagnosis as reported by married persons living with HIV in India.
Contraceptive use Before HIV diagnosis After HIV diagnosis
Men (n = 93) Women (n = 97) Men (n = 93) Women (n = 97) P valuea
Any contraceptive method 28 (30.1%) 26 (26.8%) 89 (95.7%) 92 (94.8%) <0.001
Condom use 14 (15.1%) 11 (11.3%) 86 (92.5%) 89 (91.8%) <0.001
Eﬀective pregnancy prevention methods
Oral hormonal contraception (“the pill”) 2 (2.2%) 6 (6.2%) 3 (3.2%) 10 (10.3%) 0.33
Intrauterine device 4 (4.3%) 6 (6.2%) 1 (1.1%) 0 (0%) —b
Injectables 1 (1.1%) 1 (1.0%) 0 (0.0%) 1 (1.0%) —
Tubal ligation 9 (9.7%) 9 (9.3%) 11 (11.8%) 19 (19.6%) <0.01
Vasectomy 1 (1.1%) 0 (0.0%) 3 (3.2%) 1 (1.0%) —
Any eﬀective pregnancy prevention method 17 (18.3%) 20 (20.6%) 17 (18.3%) 30 (30.9%) 0.20
Dual-contraceptive methods 4 (4.3%) 5 (5.2%) 14 (15.1%) 29 (29.9%) <0.001
Ineﬀective pregnancy prevention methods
Spermicide 1 (1.1%) 0 (0.0%) 0 (0.0%) 0 (0.0%) —
Calendar method 3 (3.2%) 1 (1.0%) 1 (1.1%) 1 (1.0%) —
aP value for the change in contraceptive use among men and women combined.
bNumbers too small to assess change.
(OR = 0.73 per increase of 50cells/mL, 95% CI = 0.62–0.87).
T oe x p l o r ep o s s i b l ed i ﬀerences between sexes, we conducted
stratiﬁed analyses. Results showed that higher CD4 count
was associated with less use of dual-contraceptive methods
amongbothmen(OR=0.73perincreaseof50cells/mL,95%
CI = 0.55–0.96) and women (OR = 0.75 per increase of 50
cells/mL, 95% CI = 0.62–0.91). In addition, among women,
use of contraception to prevent the risk of transmission of
HIV to their partner was associated with dual-contraceptive
methods use (OR = 4.48, 95%CI = 1.48, 13.54).Infectious Diseases in Obstetrics and Gynecology 5
Table 3: Correlates of dual-contraceptive methods use among married persons living with HIV in Indiaa
Variable Odds ratio 95% conﬁdence interval
Sex
Male 1.00 —
Female 2.93 1.29–6.67
Posttest HIV counselling
No 1.00 —
Yes 2.96 1.22–7.19
Used contraception to prevent risk of transmission of HIV to partner
No 1.00 —
Yes 2.30 1.01–5.20
Used contraception due to partner’s preference
No 1.00 —
Yes 2.76 1.08–7.06
Last CD4 cell count (per increase of 50cells/mL) 0.73 0.62–0.87
aOddsratiosand95%conﬁdenceintervalswerecalculatedusingamultivariatelogisticregressionmodelwithforwardselection
(using P<0.05 as the variable entry criterion).
3.4. Barriers to the Use of Eﬀective Contraceptive Meth-
ods: Qualitative Findings. We identiﬁed three key barriers
among married PLHIV to using noncondom contraceptive
methods—either alone or along with condoms: lack of
discussion by health care providers about contraceptives
other than condoms, lack of acceptability of noncondom
contraceptives to PLHIV due to misconceptions about and
overestimation of their side eﬀects, and lack of involvement
of husbands in family planning counseling, placing the bur-
den for contraception on women.
3.4.1. Lack of Discussion by Health Care Providers about Con-
traceptives other than Condoms. Most of the participants
across diﬀerent states reported that the focus of HIV and
family planning counseling for PLHIV was exclusively on
condoms, with very little discussion of other contraceptive
methods. As a man explained:
First they (HIV counselors) say “Use condoms
and have safe sex.” They don’t go to the next
level. For general people, what will they say? “If
you are not safe, a baby will be born. To avoid
that, use Copper-T (IUD) or pills or undergo
(sterilization) operation”...but for us there is no
c h o i c e .I s n ’ ti t ?A ss o o na sw eg o ,t h e yw i l ls a y
(mimicking the counselor) “My Lord! Without
putting on the cover (condom), don’t even take
it out (laughs).”
This explanation was consistent with the data from key
informant health care providers. Two key informant physi-
cians explained that doctors and counselors may emphasize
the use of condoms to the exclusion of other contraceptives.
Another physician key informant thought some doctors may
not talk about condoms or any contraceptives because they
do not want to convey the notion to PLHIV that they can be
sexually active.
Some PLHIV who had been using noncondom contra-
ceptives actually stopped using them in the belief that con-
doms would be suﬃcient. An in-depth interview participant
(awomanpeercounselor)said:“Becauseweemphasizeusing
condoms even if they already have Copper-T, many then
say, “We don’t want Copper-T, we don’t want pills. We will
just use Nirodh (condoms).” So, in some cases, emphasis on
condomusemaydiscouragepeoplefromusingothercontra-
ceptives along with condoms.
Some women reported unintended pregnancies because
they did not use condoms consistently and/or did not use
a noncondom contraceptive. For instance, a woman said:
“Once I had doubt and underwent abortion when my hus-
band was not well. (I thought), now I don’t need a child—
later we will...No, I do not use oral pills or Copper-T.”
Adequate information and tailored counselling on eﬀective
contraceptive methods might have prevented this unintend-
ed conception.
Tubal ligation for women after the birth of two or three
children is commonly practiced in India [14]. A woman
with two children who had previously visited a government
hospital for her ﬁrst delivery before she became HIV positive
recounted how the content of counseling changed after her
HIV diagnosis to focus mainly on condom use: “Four years
back, they (gynecologists) talked about Copper-T, pills, this
and that; now they focus only on condoms—then operation
(tubal ligation).” Thus, in addition to condoms, some health
care providers talked about tubal ligation with HIV-positive
couples who were seen as having completed their family.
3.4.2. Lack of Acceptability of Noncondom Contraceptives
Misconceptions about and Overestimation of Side Eﬀects of
Oral Contraceptive Pills (OCPs). Several participants, both
women and men, had misconceptions about using non-con-
dom contraceptives. For example, a woman said that she
would not want to take OCPs because she has a “hot” body:6 Infectious Diseases in Obstetrics and Gynecology
“I will tell (my husband), “Oh no! My body is usually “hot.”
I will die. Don’t even mention to me about those tablets.”
Some women, although they might never have tried
OCPs, feared side eﬀects as a result of hearing the accounts
of other women who had used OCPs. As a woman said, “I do
not have any experience (in taking OCPs), and I shall share
what I know. Those who take Mala-D (a brand of OCP) get
dizziness, body pain...I do not want to use.” This ﬁnding
suggests that reported experiences of women in informal
social networks may inﬂuence attitudes toward OCPs.
Concerns That Convalescence from Tubal Ligation Will Result
inLossofIncome. Ofthe19womeninthequantitativesurvey
who reported having had tubal ligation, ten reported having
this procedure after their HIV diagnosis. Of the 11 men who
reported that their wives had tubal ligation, two participants
indicated that their wives had the procedure following their
HIV diagnosis. In focus groups and in-depth interviews,
some HIV-positive women did not want to undergo tubal
ligation in spite of not wanting to conceive again. For instan-
ce, although advised by her doctor to undergo tubal ligation,
a woman refused because she thought the procedure would
result in loss of wages to her family: “My friends complained
of (chronic) stomach ache after the operation...Ih a v et o
work 24 hours. Only if I work will there be money. I said
“I will not do it.” My husband also agreed with me.” Ano-
ther woman said, “Once I get operated on, I will become
weak...then I need to be at home for a minimum of 6
months. We need to have a good diet. We don’t have that sort
of a luxury.” It appears that fear of inability to work and the
perception of the need for prolonged bed rest prevented this
woman from undergoing tubal ligation.
Discussions with the HIV-positive peer research staﬀ
at the community debrieﬁng meeting revealed that many
women were also concerned about the eﬀects of tubal liga-
tion on HIV disease progression. These peer research staﬀ
also believed that some health care providers were hesitant
to perform tubal ligation for women living with HIV due to
fear of contracting HIV themselves.
Concerns That Copper-T (Type of IUD) and OCPs Are Cum-
bersome and Inconvenient. Negative experiences of friends
who used Copper-T led some women to avoid it. For instan-
ce,awomanexplained:“TwoofmyneighborsgotridofCop-
per-T since it did not suit them...One can get pain or fever.
There are many problems with it.”
A key informant who had been counseling PLHIV on
family planning methods explained how diﬃcult it is to
“convince” some PLHIV to use contraceptives other than
condoms:
We say, “Even if you are on oral pills, you must
use condoms when you have sex.” We say the
same for Copper-T: “Whenever you have sex,
always use condoms”...but many would not
agree to put on Copper-T in addition to using
condoms since it has to be periodically changed.
They will make a lot of fuss—even with doctors.
Hence we do not want to talk about it (Copper-
T). Even when you talk about pills (in addition
to condoms), they would not agree. They will
say we are already on “strength pills” (vitamins)
and how many more (pills) can we take?
3.4.3. Lack of Involvement of Husbands in Family Planning
Counseling. In India, a pregnant wife often resides at her
parents’home,soherhusbandoftendoesnotaccompanyher
t oa n t e n a t a lc a r ev i s i t s .T h i sw a ss e e na sar e a s o nf o rl a c ko f
involvementofhusbandsinfamilyplanningmethods.Aman
with one child explained: “When my wife goes for (antenatal
care) visits, they also talk about family control. And they try
to convince her to have an operation (tubal ligation). But
since I am not going with her, they do not talk about family
control with me.”
Also, manymenliving withHIVreported thatvasectomy
was not discussed with them. Furthermore, they held the
misconception that vasectomy might lead to loss of virility as
well as to body weakness, which might reduce their capacity
to work.
4. Discussion
Thismixed-methods investigationsuggeststhatdual-contra-
ceptive methods are not widely used by married men and
women living with HIV in India. About one-fourth of
participants in the survey reported using dual-contraceptive
methods—condom use in combination with an eﬀective pre-
gnancy prevention method (OCPs, IUDs, injectables, or
sterilization). The main reason for the low prevalence of
dual-contraceptive methods use was the low prevalence of
the use of eﬀective pregnancy prevention methods (25%).
This was in contrast to the prevalence of condom use, which
increased from 13% before HIV diagnosis to 92% after HIV
diagnosis.
We know of no previous studies that examined the pre-
valence of dual-contraceptive methods use among PLHIV
in India. The prevalence of dual-contraceptive methods use
among PLHIV in our study (23%) was quite high compared
with women in Rwanda (1%) [15] and Malawi (1%) [16]
andwithmenandwomeninUganda(4%[17]and5%[18]),
but was lower than that reported among women in Soweto,
South Africa (33%) [19], the United States (47%) [20], and
Brazil (28%) [21].
We are aware of only two studies that examined change
in dual-contraceptive methods use after diagnosis of HIV
infection. In Brazil, dual-contraceptive methods use among
womenincreasedfrom2%beforeHIVdiagnosisto28%after
diagnosis [21].InMalawi,useamongwomenincreasedfrom
0.4% before diagnosis to 1.3% one week after diagnosis [16].
Our quantitative results were consistent with the qualita-
tive ﬁndings that health care providers restrict their discus-
sion of contraceptives with PLHIV mainly to condoms and
that non-condom contraceptives tend to lack acceptability
among PLHIV due to misconceptions about their use and
overblown concerns about their side eﬀects. These ﬁndingsInfectious Diseases in Obstetrics and Gynecology 7
indicate the need to educate married PLHIV about the bene-
ﬁts of dual-contraceptive methods and to train health care
providers to conduct this education eﬀectively, including
how to counter misconceptions and unfounded concerns
about non-condom contraceptives.
ThesurveyidentiﬁedposttestHIVcounselingasasigniﬁ-
cant correlate of the use of dual-contraceptive methods, sug-
gesting that discussion of dual-contraceptive methods with
married PLHIV during post-test counseling should be em-
phasized. Using contraceptives to prevent HIV transmission
to the spouse was also signiﬁcantly correlated with dual-con-
traceptive methods use, suggesting that appeals to personal
responsibility in counseling and educational materials might
be useful.
The very low prevalence of vasectomy reported in the
survey was consistent with the qualitative ﬁnding of lack of
involvement of many husbands in family planning counsel-
ing.Furthermore,theassociationinthesurveybetweendual-
contraceptive methods use and partner’s preference for con-
traceptionsuggeststhatinvolvementofbothpartnersincon-
traceptive counseling and decision making around family
planning might help to increase dual-contraceptive methods
use.
All contraception, including condoms, is free in India
[22]. Furthermore, the Indian government provides mone-
tary incentives for tubal ligation, vasectomy, and IUD inser-
tion [23] .T h u s ,c o s ti sl i k e l yn o tab a r r i e rt oa d o p t i o no f
dual-contraceptive methods use.
The main advantage of the dual-contraceptive methods
approach is its eﬃcacy; however, the main drawback is the
potential diﬃculty in motivating people to use two contra-
ceptive methods [7]. A review article on dual protection
argued for the importance of promoting dual protection
in spite of this diﬃculty [24]. It is therefore essential
that eﬃcient and eﬀective interventions be developed and
implemented to promote the use of dual-contraceptive
methods among married PLHIV in India, to protect their
own and their partner’s health, and to prevent unintended
pregnanciesandconsequentpossibleHIVinfectionofthein-
fant [25].
The results of this study need to be considered in rela-
tion to its limitations. First, all of our participants were as-
sociated with PLHIV networks, and more than 40% of the
participants in the qualitative component were volunteer
p e e re d u c a t o r so rp a r t - t i m ep e e ro u t r e a c hw o r k e r sf o rd i s -
trict-level PLHIV networks. Thus, our sample may have
been more educated about HIV and contraceptives than
the general population of married PLHIV. Furthermore,
our ﬁnding that counselling focused on condom use to the
exclusion of other contraceptive methods may have been
skewed by the high proportion in our sample of peer edu-
cators/outreach workers, who were trained to focus their
education of PLHIV on condom use.
Second, we did not query about consistency or concur-
rency of use of each of the various contraceptive methods
either before or after HIV diagnosis. However, we did query
about consistency of condom use in the past 3 months (after
HIV diagnosis) and reported previously that the prevalence
of consistent condom use with regular partners was 69%
among men and 73% among women [8], compared to the
prevalence of current condom use reported here (not tak-
ing consistency into account) of 92% among men and 92%
among women. Thus, the prevalence of consistent dual-con-
traceptive methods use was undoubtedly even lower than the
23%prevalenceofdual-contraceptivemethodsusemeasured
with the imperfect methodology used in the current study.
Third, we relied on the participant’s self-report of
spouse’s use of contraceptives. Men may have underreported
non-condom contraceptive use among their wives because
they were not in direct control of their use (e.g., OCPs) or
may not have known about their use (e.g., OCPs or IUDs).
Finally, it is possible that responses were inﬂuenced by
social desirability bias due to the sensitive nature of dis-
cussions of sexual behavior and contraception in India.
However, because condom distribution and promotion of
safer sex are commonplace in PLHIV networks, study parti-
cipants, who attended these networks, were accustomed to
such discussions.
Despite these limitations, our study has oﬀered useful
information for designing interventions to promote use
of dual-contraceptive methods among married men and
women living with HIV in India.
5. Conclusion
There is a need for interventions to promote use of dual-
contraceptive methods among married men and women
living with HIV in India who do not want a child or who
want to postpone childbirth. These interventions should
promote the husband’s involvement in family planning
counselling (including discussion of vasectomy) and should
provide tailored couples counselling around the beneﬁts
of dual-contraceptive methods use (prevention of infection
and pregnancy) and the recommended dual-contraceptive
methods (condoms and a highly eﬀective pregnancy preven-
tion method). PLHIV should be presented with the entire
range of contraceptive options, and common misconcep-
tions about various contraceptives should be clariﬁed. HIV
health care providers and educators and obstetricians/gyn-
aecologistsneedtobetrainedaboutthesexualandreproduc-
tive health needs and rights of PLHIV and to be competent
in oﬀering family planning counselling in a nonjudgmental,
unbiased, PLHIV-centered manner. There is a need for
national guidelines to integrate HIV care and reproductive
health services [19].
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